Bei Zhou
Xinxiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PPAB001, a novel bispecific antibody against CD47 and CD24, enhances anti-PD-L1 efficacy in triple-negative breast cancer via reprogramming tumor-associated macrophages towards M1 phenotype.
Journal: International immunopharmacology
Published: September 08, 2024
Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy.
Journal: Cell communication and signaling : CCS
Published: September 04, 2023
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy.
Journal: Molecular therapy oncolytics
Published: April 28, 2023
A novel synthetic chalcone derivative, 2,4,6-trimethoxy-4'-nitrochalcone (Ch-19), exerted anti-tumor effects through stimulating ROS accumulation and inducing apoptosis in esophageal cancer cells.
Journal: Cell stress & chaperones
Published: July 08, 2022
The Comparison of PCR Kits for the Detection of Erythrocytic Parasites on Filter Paper.
Journal: Journal of tropical medicine
Published: April 05, 2022
RIG-I Promotes Cell Death in Hepatocellular Carcinoma by Inducing M1 Polarization of Perineal Macrophages Through the RIG-I/MAVS/NF-κB Pathway.
Journal: OncoTargets and therapy
Published: April 22, 2020
SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway.
Journal: OncoTargets and therapy
Published: May 02, 2019
Controllable synthesis and adjustable antineoplastic activity of bovine serum albumin-conjugated PbS/Ag2S core/shell nano-composites.
Journal: Journal of inorganic biochemistry
Published: January 11, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026